Characteristics of C-kit+ cells derived from the human fetal liver
Li-zhen Ling,Yan-hong Ni,Ya-li Hu,Ya-yi Hou,Wen-qun Jiang,Hong-ping Ye
2009-01-01
Abstract:BACKGROUND: Stem cells are few in adult animal liver, and problems on in vitro amplification and undifferentiation still do not solved. Many scholars have predicted that embryonic hepatic stem cells have inducible clinical application. Presently, C-kit has been selected as a common marker of studing hepatic stem cells. It is found that C-kit antigen participates in growth and development of hepatic stem cells. OBJECTIVE: To investigate the methods of isolation and culture condition of C-kit+ cells in human fetal liver and the characteristics of growth and differentiation in vitro. DESIGN, TIME AND SETTING: The cytology in vitro observation was performed at the Medical School & State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University from October 2005 to March 2008. MATERIALS: Liver C-kit+ cells were obtained from 32 aborted fetal samples at the Drum Tower Hospital of Medical School of Nanjing University. Percoll separating medium was supplied by Pharmacia Company. Ficoll separating medium was purchased from Haoyang, China. Epidermal growth factor and hepatocyte growth factor were bought from R&D Company. METHODS: Fetal liver was obtained sterilely. Monoplast suspension was collected by collagenase digestion and mechanical separation, and then centrifuged using 1.070 g/mL Percoll separating medium and 1.077 g/mL Ficoll separating medium. Cells achieved from the interface of separatory liquids were cultured in DMEM/F12 medium, supplemented with 0.1 volume fraction of fetal bovine serum, 20 μg/L hepatocyte growth factor and 40 μg/L epidermal growth factor, for 9 days. MAIN OUTCOME MEASURES: Number of C-kit+ cells, characteristics, morphology, growth and differentiation of cells achieved from the interface, phenotype and C-kit markers of cells. RESULTS: Proportion of C-kit+ cells was 1.28% in non-separation hepatocytes. Ficoll and Percoll could improve the harvest of C-kit+ cells derived from fetal liver, and the actual number of C-kit+ cells was 74.21% and 72.15% in triangle region. But absolute number was still limited. There was no significant difference in morphology and growth using the two separating medium. Immunocytochemical staining showed four kinds of cells. The first type was C-kit+ cell colony. The second type was cells positively expressing CD29+, CD90+, CD34-, C-kit- (characteristics of mesenchymal stem cells) and slightly expressing cytokeratin 19 (characteristics of bile duct cells). The third type was cells strongly expressing cytokeratin 19 and negatively expressing C-kit antigen. The fourth type was cells highly expressing CD45 and weakly expressing CD34, CD90 and C-kit. After induction, keratin 19 of interface cells was strongly expressed, but negatively expressed C-kit, albumin, alpha fetoprotein and cytokeratin 18. CONCLUSION: In the fetal liver, number of C-kit+ cells is few. Ficoll and Percoll could improve the harvest of C-kit+ cells derived from fetal liver. There is mesenchymal stem cells and duct cells type, and it can improve the growth of C-kit+ cells. Mesenchymal stem cells can differentiate into duct cells.